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Abstract
Establishing Zebrafish (Danio Rerio) as a Model for Orofacial Research
By Kevin Amir Ghaffari, B.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University
Virginia Commonwealth University, April 2017
Major Advisor: Robert M. Tombes, Ph.D., Vice Provost, Department of Life Sciences

Across species, the face and more specifically the mouth, serves as an essential
facet of everyday life. Amongst humans the mouth serves as a tool for the ingestion of
food, a marker for facial recognition and a medium for communication. In order for the
mouth to properly form, a series of precise growth and fusion events are needed. In
order to insure that these events are orchestrated properly is a wide array of signals,
transcription factors and epigenetic regulators. Due to the needed precision of these
events, congenital birth defects of the face such as cleft lip and cleft palate are some of
the most common worldwide.
In order to support existing and identify new developmental processes involved in
mouth formation, we have utilized the effective model, Danio to study the molecules and
events implicated in orofacial development. This was accomplished by developing a
novel confocal imaging technique that allows for visualization of the forward facing
zebrafish. Using this imaging technique we were able to establish when the embryonic
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mouth first forms in zebrafish. Additionally, we recapitulated cleft-palate phenotypes
shown in previous literature with the imaging method. Utilizing this technique, we then
sought to further establish the role of Ca2+ signaling in proper orofacial morphogenesis
and determine if the serine/threonine protein kinase, Ca2+/calmodulin-dependent protein
kinase type-II (CaMK-II), has a role in proper orofacial developmental.

Introduction
Embryonic (Primary) Mouth Formation
The embryonic or primary mouth is the term used to identify the initial opening
between the foregut and the external environment (Dickinson and Sive, 2006). The
primary mouth forms from a region that is missing mesoderm and is known as the Early
Anterior Domain or EAD (Dickinson and Sive, 2006, 2007). The EAD serves as a
signaling center that coordinates development of the face with its multifunctional role.
Transforming the primary mouth into that of the secondary or adult mouth is a multistep
process, starting with the removal of the basement membrane that separates ectoderm
and endoderm in the EAD (Dickinson 2016). In vertebrates, neural crest quickly
migrates anteriorly after the loss of the basement membrane and surrounds the primary
mouth, guided by signaling that originates in the EAD (Dickinson and Sive, 2006;
Soukup et al., 2013). In mammals and amphibians, the mouth opening is produced after
contact is made between invaginating primary mouth ectoderm and foregut endothelium
in a depressed region known as the stomodeum (Dickinson and Sive 2009; Soukup et
al., 2013; Waterman, 1977, 1985). In Xenopus, stomodeal ectoderm and endodermal
layers are reduced via apoptosis in what ultimately leads to perforation of the
buccopharyngeal membrane (Dickinson and Sive, 2006). Different from this, the rupture
of the buccopharyngeal membrane and formation of the zebrafish mouth opening is
thought to occur after changes in intercellular junctions and cell orientations (Hamlett et
al., 1996; Waterman and Kao, 1982). While the specific mechanisms controlling the
rupturing of this oral membrane are unknown, there are a host of abnormalities
implicated when it is not properly ruptured such as persistent buccopharyngeal
1

membrane and resulting choanal atresia (Verma 2009). Despite the clear importance of
the embryonic mouth, there is a lack of data on what factors are necessary for this
structure to form and how disruptions to the embryonic mouth’s development could
ultimately effect secondary mouth development.
Primary Palate, Midface and Upper Lip Formation
Arising from the embryonic mouth are several structures, namely the primary
palate (and secondary palate for amniotes), midface and upper lip. By the fourth week
of development the human face begins to form with migrating neural crest cells
combining with mesoderm and the epithelial cover to establish the facial primordia
(Jiang 2006). From here neural crest-derived facial mesenchyme contributes to the
facial skeleton whereas mesoderm-derived cells form the muscles found in the face
(Noden, 1978; 1983; 1988). The primary palate forms from the fusion of the maxillary,
medial nasal and lateral nasal prominences in a series of highly regulated events. While
the differences seen in head shape between organisms are more than likely initiated
during embryonic development, there are negligible differences between species at
early stages of facial development (Abzhanov et al. 2004). Something to note, however,
is that some differences do exist between amniotic and non-amniotic models as it
appears direct fusion events occur in fish species without the need for a midline
epithelial seam (Swartz 2011). Furthermore, amniotes have a secondary palate that
forms via outgrowths of the maxillary prominences, a structure that has been heavily
implicated in cleft palate pathogenesis. Nevertheless, a host of recent genetic studies
have shown the value zebrafish have as a model organism for palate research. As an
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example, disruption of SHH causes defects in the palatal skeleton for human, mouse
and zebrafish (Belloni et al., 1996; Chiang et al., 1996; Eberhart et al., 2006).
Signaling Pathways Implicated in Mouth Formation
Proper development of the orofacial region is controlled by species specific
fusion events between the maxillary, medial nasal, and lateral nasal prominences.
Differences between where these fusion events occur is what ultimately leads to the
differences in head shape between organisms. Controlling these events in chick, mouse
and zebrafish are major developmental signaling pathways such as BMP, HH, FGF,
PDGF and Wnt (Dickinson 2016). While these developmental pathways have
independent roles in orofacial morphogenesis, there has also been evidence of genetic
cross-regulation as well as crosstalk intracellularly to control aspects of tissue patterning
and cell proliferation (Jiang 2006). Previous literature showed inhibition of both BMP
and HH signaling would lead to cleft-like phenotypes, something we wished to
recapitulate with our new imaging technique.
BMP Signaling Pathway
The bone morphogenetic protein (BMP) family represents a class of signaling
molecules that play a role in cell proliferation, morphogenesis, survival and
differentiation during development. BMPs are multifunctional morphogens belonging to
the TGFb (transforming growth factor b) superfamily of signaling molecules. In the
orofacial region, BMP signaling is crucial for the regulation of cell proliferation,
extracellular matrix synthesis, and cellular differentiation (Mukhopadhyay 2008). BMPs
were first identified and isolated from demineralized bone matrix and characterized due
3

to their function in ectopic bone formation in vivo (Wozney et al. 1988; Lyons et al.
1990). Afterwards, these same growth factors were found to be expressed widely in the
vertebrate embryo and fetus where they were seen to have significant roles in
regulation of neurogenesis, ossification, organogenesis and more (Lyons et al. 1990;
Hogan, 1996a; Kishigami et al., 2004). BMP family members are known as one of three
classes, either osteogenic proteins (OP), cartilage derived morphogenetic proteins
(CDMP), or growth and differentiation factors (GDF). From these classes, BMPs are
further derived into subfamilies based on sequence homology and phylogenetic analysis
(Hogan, 1996b). BMP signaling is initiated by growth factor interaction between the type
I (ALK2, ALK3, BMPRIA, ALK6, BMPRIB) and type II (BRII, ActRIIA, ActRIIB) receptors
(von Bubnoff and Cho, 2001; Nohe et al., 2004). After activation by the appropriate BMP
ligand, hetero-oligomers are formed by the type I and type II receptors, which then leads
to initiating Smad-mediated intracellular signaling cascades that regulate transcription
and expression of various target genes. BMP-induced receptor activation starts two
different types of signaling pathways, the canonical pathway and the mitogen-activated
protein kinase (MAPK) pathway. The canonical pathway involves activation of receptorspecific Smad 1, 5, and 8, followed by formation of a complex including the common
Smad, Smad 4, which translocates into the nucleus to regulate transcription of BMP
target genes (Yamamoto et al., 1997; Hollnagel et al., 1999; Nohe et al., 2004). The
MAPK pathway includes p38, c-jun-N-terminal kinase (JNK), and extracellular signalregulated kinase (ERK) pathways (Gallea et al., 2001; Zhao et al., 2002). Additionally,
BMPs have been linked to activating PI3 kinase and PKC pathways (Kishigami and
Mishina, 2005). After entering the nucleus, BMP type I receptor-specific Smads (BR-
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Smads), Smad 1, 5, and 8, interact with DNA binding proteins which bind to specific
sequences known as Smad-binding elements (SBEs) in the promoters of BMP target
genes (Ogata et al., 1993; Korchynskyi et al., 2003). Targeting these genes in
combination with BMP treatment and inhibition allows us to study the developmental
significance of BMP signaling.
BMP Signaling Pathway in Craniofacial Development
Several studies show that BMP signaling plays a pivotal role in proper
development of the orofacial region (Mukhopadhyay 2008). BMP has been implicated in
the early patterning of the head, the development of cranial neural crest cells, apoptosis
regulation and facial patterning. BMP signaling also helps regulate development of
mineralized structures such as cranial bones, maxilla, mandible, palate and teeth. BMP
has also been implicated to play a role in proper orofacial morphogenesis and cleft
palate formation as it is suspected that its regulation of proliferation in the anterior
palatal shelf mesenchyme and its ability to modulate apoptosis are the key factors as to
whether the developing mouth is perturbed or not. Furthermore, it is possible that the
small differences in BMP signaling are what ultimately lead to the variability in human
craniofacial features as well as the differences seen in tissue physiology and disease
susceptibility (Graf 2015). Literature also shows that CNCC must receive BMP signaling
for proper palate development in zebrafish. BMP signaling has been implicated in
mediating differentiation and/or survival/proliferation of palatal precursors after
condensing upon the oral ectoderm (Swartz 2011). Both the anterior crest and the oral
ectoderm have been shown to express bmp2b from 36 to 48hpf (Swartz 2011).
Similarly, bmp4 was shown to be expressed in anterior CNCC and the oral ectoderm
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from 36 to 40hpf (Swartz 2011). Beginning at 44 and 48hpf, a small population of
posterior CNCC express bmp4, with the oral ectoderm weakly expressed bmp4
between 44 and 72hpf (Swartz 2011). Moreover, literature shows that BMP signaling is
required for proper palatogenesis and craniofacial development in zebrafish. When
using smad5 mutant fish in which downstream Bmp receptor signaling is defunct, the
palatal skeleton is almost entirely lost with only small amounts of the trabeculae and
surrounding cartilages remaining (Swartz 2011; Liu et al., 2005).
Hh Signaling Pathway
The Hedgehog signaling pathway plays a key role in normal vertebrate
development (Lee et al., 2006; Briscoe and Therond, 2013) and maintenance of
postnatal tissue homeostasis (Petrova and Joyner, 2014). Mammals have three
Hedgehog-family members, Indian hedgehog (Ihh), Desert hedgehog (Dhh), and Sonic
hedgehog (Shh); of these three, Shh has the most pivotal role in regulating
developmental processes (Cobourne 2016). Shh is released from the surface of
signaling cells as a dual-lipidated protein that can be modified by addition of cholesterol
and palmitate groups at the C and N-terminal regions, respectively (Pepinsky et al.,
1998; Porter et al., 1995). In order for Shh to be secreted from the cell a combined
activity is needed between Dispatched (Disp), a multipass sterol-sensing domain protein
(Caspary et al., 2002; Kawakami et al., 2002; Ma et al., 2002) and Scube2 (Signal
peptide CUB EGF-like domain-containing protein), a secreted glycoprotein; both of
these proteins interact with Shh through its cholesterol moiety (Creanga et al., 2012;
Tukachisnky et al., 2012). Once secreted, Shh can go on to signal within embryonic
tissues at long and short-range (Gritli-Linde et al., 2001). Reception at target cells is
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mediated primarily through Patched1 (Ptch1), a twelve-pass transmembrane protein,
which functions as a ligand-independent inhibitor in its resting state (Goodrich et al.,
1996). If Shh is absent, Ptch1 accumulates and represses the activity of Smoothened
(Smo), a G-protein coupled receptor (GPCR)-like protein (Corbit et al., 2005; Rohatgi et
al., 2007) that is essential for signal transduction (Zhang et al., 2001). Downstream of
interactions between Smo and Ptch1, intracellular signaling is coordinated directly via
processing of Gli (Glioma-associated oncogene family members; Gli 1-3) transcription
factors and gating their entry into the nucleus (Haycraft et al., 2005). Modulating the
interaction between Shh, its receptors, and the direct transcriptional targets it has (Gli1,
Ptch1, Hhip1) allows for us to explore the role Hh signaling has on development of the
zebrafish face.
Hh Signaling Pathway in Craniofacial Development
Hedgehog signaling has been implicated in driving outgrowth of the upper face
(Hu et al. 2003; Hu & Marcucio, 2009) as well as patterning the midline for both the
brain and the face (Chiang et al. 1996). Proper temporal based expression of Shh, the
most studied ligand in the hedgehog signaling pathway, is critical for proper
development of the embryonic facial ectoderm, neuroectoderm, pharyngeal endoderm
and the outgrowth of the frontonasal process (Cordero et al., 2004). Lack of proper Shh
expression has been implicated in facial clefting while overexpression has been linked
to widening of the head leading to a condition known as hypertelorism. Interestingly,
early hedgehog signaling was also shown to regulate primary mouth size in Xenopus as
well as having a role on oral opening size throughout development (Liu 2014).
Furthermore, crosstalk between Shh and the BMP signaling pathway has been well
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documented and Shh signaling has been shown to play a pivotal role in coordinating
reciprocal epithelial-mesenchymal interactions between FGFs, BMPs, cyclins and Fox
transcription factors that appear to be essential for normal palatal development (Hu
1999). It has also been shown that, as in mouse, the oral ectoderm of zebrafish also
expresses Shh (Miller et al., 2000). In fact, after a more detailed study of expression
patterns by Swartz et al., it was shown that the oral ectoderm strongly expresses Shh
throughout palatogenesis in zebrafish (Swartz 2011). Lastly, in zebrafish, separate early
and late requirements for Hh signaling have been shown. When fish were treated with
higher concentrations (50-100µM) of the Smoothened antagonist cyclopamine for any 4hour period between 0 and 24hpf it caused a complete loss of the anterior
neurocranium, showing an absolute requirement for Hh signaling in anterior
neurocranium development during NC migration (Wada 2005). Oddly enough, 50µM
cyclopamine treatments of embryos older than 24hpf (after NC migration has taken
place) still disrupted trabecular and ethmoid development (Wada 2005). Treatment
between 30-35hpf eliminated the medial ethmoid plate while trabecular cartilages were
still well formed, resulting in a large palatal cleft (Wada 2005). Only after 48hpf were
treatments seen to be non-effective at causing abnormalities in palatal development.
Ca2+ Signaling in Craniofacial Development
In order to explore new territory with our imaging technique we decided to
investigate the role of Ca2+ signaling in orofacial morphogenesis. Ca2+ supplementation
has been linked with a reduced risk of developing NSOFC (Nonsyndromic orofacial
cleft) (Sabbagh et al. 2015) and lower blood calcium levels are linked to the often cleftassociated DiGeorge syndrome. CaMK-II has been implicated in tongue abnormalities
8

in mice which typically led to facial morphological defects such as cleft palate (Xiao et
al. 2014). Furthermore, our lab has previously shown CaMK-II to have a role in cloacal
cilia stabilization, opening up the possibility for CaMK-II to have a role stabilizing cilia
elsewhere, such as the face. Making a connection between Ca2+ signaling and
zebrafish palatogenesis is a way to show the strength of our technique when
investigating pathways that are not as explored.
CaMK-II
Ca2+/Calmodulin-dependent protein kinase type II (CaMK-II) is a ubiquitously expressed
serine/threonine protein kinase. CaMK-II is encoded by four genes (α, β, γ, δ) in
mammals, producing over thirty-five different splice variants (Tobimatsu et al., 1989;
Schworer et al., 1993; Hudmon and Schulman, 2002; Tombes et al., 2003). The CaMKII holoenzyme contains 12 functional subunits. Each subunit has an amino terminal
catalytic domain that is followed by an autoregulatory domain, a series of variable
inserts, and a carboxyl terminal association domain. The catalytic domain contains an
ATP binding site that has a specific sequence for substrate binding which leads to
subsequent phosphorylation and activation. The mediator of the holoenzyme’s activity is
the autoregulatory domain. Within this sequence of residues is an autoinhibitory
domain, an autophosphorylation site, and a CaM (calmodulin)-binding site. When CaM
binds to its domain (residues 296-311), the catalytic domain is no longer inhibited and is
free to phosphorylate protein substrates, including itself, at Thr286(a)/Thr287(b, d, g) which
is key to its role in many signal transduction pathways (Braun and Schulman, 1995).
The various isoforms of CaMK-II differ in their tissue expression, cellular localization,
and sub-cellular compartmentalization (Schworer et al., 1993; Brocke et al., 1995; Bayer
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et al., 1999; Tombes et al., 1999; Soderling et al., 2001; Hudmon and Schulman, 2002).
In response to increased levels of intracellular calcium, CaMK-II phosphorylates a
diverse set of substrates of the cytoskeleton, sarcoplasmic reticulum, and the postsynaptic density (Braun and Schulman, 1995). Once activated, these protein substrates
form complexes of scaffolding molecules for signal transduction and other neuronal
pathways. The extensively studied alpha CaMK-II has been implicated in behavior,
memory, long-term potentiation and neuronal plasticity. In zebrafish, CaMK-II is
encoded by seven genes (α, β1, β2, γ1, γ2, δ1, δ2). Over 20 splice variants have been
identified from these seven genes, with the variants existing in locations that indicate
CaMK-II has a multi-functional role in transducing Ca2+ signals in the earliest phases of
vertebrate development (Rothschild et al., 2007). Amongst these regulatory roles,
zebrafish CaMK-II has been implicated in central nervous system function, convergent
extension movements, axis formation during gastrulation, inner ear development, and
more (Rothschild et al., 2013; Rothschild et al., 2007).
Zebrafish as a Model for Orofacial Morphogenesis
While the human face does not resemble the zebrafish (Danio Rerio) face, both
humans and zebrafish are deuterostome vertebrates with conserved developmental
pathways and mechanisms. For example, it has been documented that portions of the
first stream of CNCC in zebrafish come to occupy frontonasal and maxillary domains as
can be seen with its amniotic model counterparts. By 60hpf these cells have given rise
to specific subsets of the palate with a more critical time period of dynamic cell
rearrangements occurring between 36 and 48hpf, ultimately driving the morphogenesis
of the zebrafish palate (Swartz 2011). Due to zebrafish developing faster than other
10

organisms currently used for orofacial research (chick, frog, mouse) Danio is a
promising model for discovery of new molecules required for orofacial development at
specific time periods. Furthermore, zebrafish serve as an excellent model organism due
to their rapid high-yield of offspring and ease in which genetic changes may be
introduced. Another important feature to note is that zebrafish embryos are completely
transparent which allows for non-invasive imaging techniques when manipulating genes
and monitoring development. Despite the strength of Danio as a model organism for
embryonic development the majority of attention has been placed on adult jaw, teeth,
and skull formation in zebrafish due to the large degree of cartilage and bone growth
and ease in which Alcian blue and Alizarin red staining can be utilized. Moreover, our
lab believes researchers have previously avoided using zebrafish to study early mouth
development due to the misconception that Danio’s developing body curvature would
prevent imaging the face clearly. Navigating around the fears of early zebrafish face
imaging, we were able to capitalize on the rapid development of Danio and show the
strength this organism has in not only recapitulating phenotypes seen in mammalian
models but also for exploring new areas of orofacial research.
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Materials and Methods
Zebrafish strains and care
Wild type (AB and WIK), Tg(Fli1:GFP), and Tg(Hsp70I:CA Alk6-p2a-Kikume) fish
embryos were obtained through natural matings and raised at 28.5°C, as described
previously (Kimmel et al., 1995). Fli1:GFP transgenic embryos express GFP in
cartilage-producing cells as well as vasculature (Lawson and Weinstein, 2002).
CaMK-II inhibition
Zebrafish embryos were incubated in 10 μM KN-93 in 2 ml of E3 (5.0mM NaCl,
0.17mM KCl, 0.33mM CaCl2, 0.33mM MgSO4) continuously, starting at 24, 48, and
50hpf respectively. At 72hpf the embryos were pipetted out of solution and treated and
fixed in 4% paraformaldehyde. After 24 hours they were pipetted into individually
labeled Eppendorf tubes and washed 3-4x with PBTx. Next the embryos were counter
stained with Rhodamine Phalloidin (1:500) and left in a refrigerator wrapped in
aluminum foil for 24 hours. After 24 hours, the embryos were washed 3-4 more times
with PBTx and then prepared for imaging. Embryos were not typically dechorionated
prior to treatment.
BMP inhibition
Zebrafish embryos were incubated at 28.5°C in 10 μM DMH1 in 2 ml of E3
continuously, starting at 24, 42, and 48hpf respectively. At 72hpf the embryos were
pipetted out of solution and fixed with 4% paraformaldehyde. After 24 hours they were
pipetted into individually labeled Eppendorf tubes and washed 3-4x with PBTx. Next the
embryos were counter stained with 1μL Rhodamine Phalloidin and left in a refrigerator
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wrapped in aluminum foil for 24 hours. After 24 hours, the embryos were washed 3-4
more times with PBTx and then prepared for imaging. Embryos were not typically
dechorionated prior to treatment.
Hedgehog inhibition
Zebrafish embryos were incubated in 100 μM cyclopamine in 2 ml of E3
continuously, starting at 22 and 44hpf respectively. At 72hpf the embryos were pipetted
out of solution and treated with PFA 4%. After 24 hours they were pipetted into
individually labeled Eppendorf tubes and washed 3-4x with PBTx. Next the embryos
were counter stained with 1μL Rhodamine Phalloidin and left in a refrigerator wrapped
in aluminum foil for 24 hours. After 24 hours, the embryos were washed 3-4 more times
with PBTx and then prepared for imaging. Embryos were not typically dechorionated
prior to treatment.

CaMK-II antibodies
Immunolocalization using anti-autophosphorylated CaMK-II (anti-P-CaMK-II;
phosphorylated at Thr287), CaMK-II and total CaMK-II antibodies has previously been
described by this laboratory (Easley et al., 2006; Rothschild et al., 2011). The antiphospho-Thr287 (anti-P-T287) antibody detects CaMK-II proteins across species and the
total CaMK-II antibody reacts with the C-terminal region of all CaMK-II proteins.
Alk6 heat shock
A previously generated heat-shock inducible constitutively active BMP receptor
1B plasmid was used as previously described (Row et al., 2016). In short, the coding
sequence of a mutant constitutively active (Q207D) mouse ALK6 (caalk6) without the
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stop codon was inserted into a heat-shock vector to create hsp70l:caalk6-p2a-NLSkikume (abbreviated HS:caalk6) flanked by tol2 transposable element arms (MaciasSilva et al., 1998). A stable transgenic line of HS:caalk6 was generated by injecting the
plasmid DNA along with in vitro transcribed tol2 transposase mRNA (25 pg of each per
embryo) into 1-cell stage embryos and screening injected animals when they became
adults for germ-line transmission (Kawakami, 1998). Embryos were incubated at 40°C
for thirty minutes in a water bath to activate the CA ALK6 ubiquitously. We would like to
thank the Martin lab for providing us with this line.
Confocal Microscopy
Two different confocal microscopes were used for imaging the forward facing
zebrafish embryos. In order to image the faces, a novel technique was developed
(Figure 5). First, fish were raised to desired developmental time point (typically 72hpf)
and fixed with PFA 4% in respective Eppendorf tubes. After 24 hours, PFA was washed
out with PBTx 3-4 times and 1μL of Rhodamine Phalloidin was added to solution. After
24 hours 3-4 more PBTx washes were performed. At this time the fish were pipetted
from the Eppendorf tubes and into a small petri dish with 100% glycerol. Once in the
petri dish, a small cutting utensil was used to precisely cut off the faces which were then
pipetted onto a mounting slide. Using 3-4 cover slips per side on the mounting slide, the
slide was mounted onto a confocal microscope and focused appropriately. Slight
adjustments were made using fingers until the face was forward facing. Once forward
facing, the image was focused on up to 20x magnification and was converted into a MIP
(Maximal intensity projection) so that all sections of the z-stack are represented. Due to
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confocal imaging of the face throughout the entire z-plane of the skull, we can visualize
the internal features of the mouth in addition to the external protruding mouth.
Face Measurements
In order to quantify the qualitative fish face images that have been generated
from our experiments a series of measurements were taken and compared between
experimental and control groups. Eight measurements were utilized for each fish face: a
brain measurement (height from top of skull to above upper mouth region), distance
between outside of the eyes (width of head), distance between inner eyes (intercanthal
distance), width of the top and bottom of the mouth at both the protruding level of the zstack as well as the internal portion of the z-stack, and mouth height from top to bottom.
These measurements were then averaged and graphed, with error bars on each
categorical measurement representing the standard deviation within each group. With
these facial measurements statistical analyses were performed using the program JMP
Pro 12. T tests were utilized comparing control and treatment group fish face
measurements and whether a significant difference existed in measurements between
the groups.
Fish Face
We believe our work will make significant contributions to FishFace, a publicly
accessible atlas for zebrafish craniofacial development. Currently FishFace focuses on
pharyngeal arch formation and skull anatomy and has no data on mouth formation in
the zebrafish. By focusing on these later stages of development and analyzing when
ossification of the zebrafish skull occurs there has been a neglect in the area of
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research where the zebrafish shines as a model organism, the early embryonic stages.
By elucidating mouth formation, developmental timing and the embryonic development
patterns associated with proper mouth formation we can give the zebrafish craniofacial
community new information to study primary palate abnormalities such as cleft lip and
cleft palate.
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Results
Identifying when the Zebrafish Mouth Opens
After reviewing literature on primary mouth formation by Dickinson et al. we
decided to investigate when the primary mouth first forms in zebrafish and whether
primary mouth formation can be studied in zebrafish (Dickinson 2016). First, a
technique was developed to image the forward facing zebrafish so that its mouth, brain,
and intercanthal distance could be easily measurable and visible (Figure 1, Figure 5).
Additionally, the technique includes creating a MIP, or maximal intensity projection,
which allows for analysis of the mouth not only externally but throughout the entire face
and skull. Forward facing images are standard for most other model organisms when
conducting craniofacial research. Utilizing the proposed technique, a series of
developmental time points were tested in order to measure the technique’s efficacy and
determine broadly when the mouth is open in zebrafish. In order to do this, wildtype
zebrafish were raised to 36, 48, 60, 72hpf, and 5dpf respectively. After fixing the
embryos at the appropriate developmental time point, they were treated with Phalloidin
488 – allowing for us to image them using the new confocal microscopy technique
(Figure 5). An external mouth was not visible at 36hpf but was visible at 48hpf. From
this initial time point analysis, it was determined that the mouth first opens in zebrafish
between 36hpf and 48hpf (Figure 2). After establishing that the mouth opens between
36hpf and 48hpf, we decided to investigate in more detail the exact time in which one
can expect the zebrafish mouth to be open. Fixing embryos one hour apart between
36hpf and 48hpf resulted in our discovery that the zebrafish embryonic mouth is first
open at approximately 45-46hpf (Figure 3, Figure 4). Furthermore, by imaging fish faces
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during this range of early embryonic development we were able to confirm that the
technique is viable despite natural body curvature in developing zebrafish (Figure 3).
Moving forward, this knowledge of when the zebrafish mouth opening is formed was
utilized to time future drug treatments in addition to being used as a reference point
when considering normal orofacial morphogenesis and how morphogenesis may
become impaired after being acted upon by various factors.
Recapitulating BMP Craniofacial Defects
Utilizing our new imaging technique, we decided to next be able to recapitulate
the phenotypes previously seen in frog, fish, and mice when the BMP signaling pathway
was antagonized (Swartz 2011; Liu et al., 2005; Mukhopadhyay 2008). Previously,
inhibition of BMP signaling was shown to cause almost complete loss of the palatal
skeleton (Swartz 2011; Liu et al., 2005) as well as loss of several cartilaginous
structures (Schilling et al., 2011). In order to possibly recapitulate these abnormal
phenotypes, the small molecule inhibitor DMH1 was used. DMH1 specifically
antagonizes the intracellular kinase domain of BMP type I receptors, allowing for
inhibition of basal Smad phosphorylation. We decided to treat developing Tg(Fli1:GFP)
embryos with DMH1 at 24, 40, 42, and 48hpf respectively (Figure 6). After allowing for
all of the embryos to develop to 72hpf, they were counterstained with Rhodamine
Phalloidin. After mounting the fish and properly orienting their face forward, maximal
intensity projections were created via confocal microscopy in order to compare the
phenotypic effects of the antagonist when starting treatment at different developmental
time points. Out of the four time points treated with DMH1, the 24hpf treatment group
had the most prominent orofacial abnormalities (Figure 7). In order to quantify these
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differences a series of measurements were created across consistent landmarks of the
zebrafish face. Amongst the facial features that were observed via the MIPs are the
brain length (top to bottom), the distance between the outside of the eyes (head width),
the distance between the inside of the eyes (intercanthal distance), and the mouth
height (top to bottom). Within the single z-stack images we also measured for the width
of the top and bottom mouth both internally and externally (protruding mouth). From
these measurements we were able to determine that not only did the fish faces have
consistent orofacial clefting at this time point, they also had a smaller distance between
their eyes and the width of the top and bottom of their outward mouth (Figure 8). This
was interesting as it was the first indication that our imaging technique could also be
used to observe defects in the skull that could then possibly modify mouth size and
shape. After confirming our ability to recapitulate orofacial clefting with the use of
DMH1, we decided to perform a heat shock experiment with a constitutively active
HS:CA Alk6 transgenic line of zebrafish. By heat shocking for 30 minutes at 40°C at
18hpf we were able to induce overexpression of BMP signaling and look at the
developmental outcomes when fixed at 72hpf. After counter-staining with Rhodamine
Phalloidin a series of maximal intensity projections were created of both heat shocked
fish and their control counterparts. Severe phenotypes were exhibited when heat
shocked at 18hpf (Figure 9) showing a consistent cleft-like phenotype and distinct
abnormalities in craniofacial shape and size. When comparing measurements of our
established facial markers, there was a significant size difference seen between the
heat shock fish and control fish for total mouth height (p = 0.0415), and the upper mouth
internally (p = 0.0455) and externally (p = 0.0275) (Figure 10).
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Recapitulating Hh Craniofacial Defects
Next, we sought to recapitulate the craniofacial defects exhibited by inhibition of
another known key craniofacial development pathway, the Hedgehog signaling pathway
(Hu et al., 2003; Cordero et al., 2004). Previous literature showed that inhibition of the
Hedgehog signaling pathway can lead to loss of cartilage structures and impairment of
neurocranium development (Wada 2005). In order to possibly recapitulate these
phenotypes, we utilized the Smoothened antagonist cyclopamine and treated at two
different time points, 22 and 44hpf. After allowing for all of the embryos to develop to
72hpf they were counterstained with Rhodamine Phalloidin. After mounting the fish and
properly orienting their face forward, maximal intensity projections were created via
confocal microscopy in order to compare the phenotypic effects of the antagonist when
starting treatment at different developmental time points. Both the 22hpf treatment
group as well as the 44hpf treatment group displayed clear cleft-like phenotypes as well
as signs of other craniofacial abnormalities (Figure 11). When creating measurements
of the fish faces using the same landmark features, we were able to determine that a
difference existed between the control fish face and that of the 44hpf treatment group in
regards to head width, intercanthal distance and the width of the upper protruding
mouth (Figure 12). While significance levels could not be calculated for the 22hpf
treatment group a significant size difference (p = .0043 and p = .0476 respectively) was
seen between control lower protruding mouth size and upper internal mouth size when
compared to fish incubated with cyclopamine at 44hpf (Figure 12). The distinct
phenotypes we were able to generate with the cyclopamine treatments further
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established the use of our imaging technique as a way to visualize disease states when
studying the face.
CaMK-II’s role in Craniofacial Development
In order to determine the role CaMK-II has in craniofacial development we
decided to first look at expression levels of auto-phosphorylated and total CaMK-II in the
mouth region. Using anti-autophosphorylated CaMK-II and total CaMK-II antibodies we
were able to detect expression of both auto-phosphorylated CaMK-II surrounding the
perforated mouth as well as total CaMK-II in the same region (Figure 13). After
confirming that both P-CaMK-II and CaMK-II are expressed in the orofacial region we
then decided to observe the effects of the calmodulin binding antagonist of CaMK-II,
KN93. We decided to incubate zebrafish embryos with KN93 at three different time
points: 24, 48, and 50hpf respectively. After allowing for all of the embryos to develop to
72hpf, they were counterstained with Rhodamine Phalloidin. After mounting the fish and
properly orienting their face forward, maximal intensity projections were created via
confocal microscopy in order to compare the phenotypic effects of the antagonist when
starting treatment at different developmental time points. From these drug treatments
the most severe craniofacial defects were exhibited by zebrafish treated at 48hpf
(Figure 14). While the other treatment periods did show some qualitative signs of
craniofacial abnormalities, it was not cleft-like and instead typically consisted of changes
in the head shape/size, creating a box-like mouth (Figure 15). Changes in features
surrounding the face that result in mouth morphological changes is what we anticipated
as previous research showed a role for CaMK-II in regulating tongue formation that,
when impaired, led to orofacial defects (Xiao et al. 2014). By measuring landmark facial
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features we were able to establish some differences between the face size and shape in
the drug treated fish and control fish. Namely, the 24hpf treatment group exhibited a
somewhat larger brain and a smaller mouth from top to bottom (Figure 16). Comparing
the 48hpf treatment group with the control showed a significant difference (p = 0.0068)
in brain size, with minor changes to mouth width also occurring (Figure 16). Potentially
causing the differences in mouth width and shape are the changes in brain size,
causing the facial prominences to compensate and fuse at abnormal locations. In
conclusion, antagonizing CaMK-II caused craniofacial defects, with the most common
phenotype being that of a “boxed” mouth. Furthermore, changes in brain size were seen
in multiple treatment groups, shedding light on another potential regulatory role for
CaMK-II.
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Figure 1. Zebrafish (Danio Rerio) Head Anatomy. Top –
48hpf, bottom – 5dpf. Wildtype fish treated with Phalloidin 488
after being fixed in 4% PFA at desired developmental time point.
Both facial images are maximal intensity projections (MIPs) that
include all sections of z-stack using confocal microscopy.
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Figure 2. Development of Zebrafish (Danio Rerio) face
at 36, 48, 60, 72hpf, and 5dpf. Wildtype fish stained with
Phalloidin 488 after being fixed in 4% PFA at desired
developmental time point. All facial images are maximal
intensity projections (MIPs) that include all sections of zstack using confocal microscopy.
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Figure 3. Development of Zebrafish (Danio Rerio) face
at 40, 42, 44, and 45hpf. Tg(Fli1:GFP) fish counter-stained
with Rhodamine Phalloidin after being fixed in 4% PFA at
desired developmental time point. All facial images are
maximal intensity projections (MIPs) that include all
sections of z-stack using confocal microscopy.
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Figure 4. Development of Zebrafish (Danio Rerio) face at 36-41, 42, 43, 44, 45,
and 48 hours post fertilization. When fixing fish before 44hpf no open mouth was
observed. At 45hpf nearly 50% of the embryos had a visible mouth, indicating this is
around the time of external perforation and opening of the embryonic mouth.
Inherently the time point cannot be exact as there are small discrepancies such as
when the eggs were harvested, developmental rate, etc. Therefore, we have
determined the primary mouth opens at approximately 45-46hpf.
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Figure 5. Technique used to mount and image forward facing zebrafish face.
First, a fish that has been treated with PFA 4% and a stain (or counter-stain in the
case of Tg(Fli1:GFP) fish) is pipetted into a dish with 100% glycerol and its face is
separated from the body with a cut spanning behind the brain and lower jaw. After
properly mounting the sectioned face onto a cover slide, adjustments are made to
orient the face forward. Using the forward facing fish a MIP (Maximal Intensity
Projection) is created using confocal microscopy in the NIS Elements software.
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Figure 6. Drug treatments with BMP type I receptor antagonist, DMH1.
Treatments were at 24, 42, and 48hpf, respectively. Once treated with DMH1,
the fish were incubated at 28.5°C until 72hpf when they were fixed with 4%
PFA and prepared for imaging. All fish were Tg(Fli1:GFP) fish counter-stained
with Rhodamine Phalloidin after being fixed in 4% PFA. All facial images are
maximal intensity projections (MIPs) that include all sections of z-stack using
confocal microscopy. The most severe phenotypes were seen at the 24hpf
treatment time period, exhibiting signs of orofacial clefting as well as a “boxshaped” mouth.
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Figure 7. Drug treatment outcomes with BMP type I receptor antagonist,
DMH1. Treatments were at 24, 40, 42, and 48hpf, respectively. Once treated
with DMH1, the fish were incubated at 28.5°C until 72hpf when they were
treated with 4% PFA and prepared for imaging. Bars represent the percentage
of fish with phenotypic changes to mouth morphology, indicated as being
phenotypically normal (blue), box-shaped (orange) or cleft-like (grey). From the
results it was concluded that DMH1 treatment caused the most significant
changes to facial development when treated at an earlier time point (24hpf).
Treatment at later time points (40, 42, and 48hpf) did not show any discernible
changes qualitatively, however subtle changes were seen in measurement
analysis.
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Figure 8. Measurement outcomes after treatment with BMP antagonist
DMH1. Measurements of the face were performed with control, 24, 42 and
48hpf treatment group fish. Average measurements were compiled with a
minimum n-value of 5 and compared across control and treatment fish. Each
bar represents the average measurement value for given treatment group
and measurement category. Error bars represent the standard deviation
within the given treatment group or control. From this data it was determined
that there was a difference between 24hpf treatment fish and control in terms
of mouth size for the upper protruding mouth, lower protruding mouth and
upper internal mouth. Other subtle changes were noted in the 42 and 48hpf
treatment groups, such as the head width (outer eye measurement) in both
groups.

30

Figure 9. Heat shock experiment with constitutively active BMPR. A
Hsp70I:CA Alk6 transgenic line was used to test constitutively active BMP
signaling. Fish were shocked at 40°C for 30 minutes at 18hpf and then left to
incubate until 72hpf when they were treated with 4% PFA and prepared for
imaging. Severe phenotypes were exhibited, showing signs of orofacial
clefting and disfigured head shape and size.
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Figure 10. Measurement outcomes after fish were shocked at 40°C for 30
minutes at 18hpf. Measurements of the face were performed with heat shock
positive and control fish. Each bar represents the average measurement value for
given treatment group and measurement category. Error bars represent the
standard deviation within the given treatment group or control. Average
measurements were compiled with a minimum n-value of 5. From this data it was
determined that a difference existed in mouth height (top to bottom), the upper
mouth when protruding and the internal upper mouth between heat shock and
control fish. Other measurement categories did not have a significant difference
between control and heat shock fish. Significant differences between
measurements were seen between overall mouth height (p = 0.0415) and the
internal / external measurements of the upper mouth (p = 0.0455 and p = 0.0275
respectively). Significance levels were tested using a t Test comparing control
and heat shock measured fish faces.
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Figure 11. Drug treatments with Hh signaling smoothened antagonist,
cyclopamine. Treatments with cyclopamine were at 22 and 44hpf,
respectively. Once treated with cyclopamine, the fish were incubated at
28.5°C until 72hpf when they were treated with 4% PFA and prepared for
imaging. All fish were Tg(Fli1:GFP) fish counter-stained with Rhodamine
Phalloidin after being fixed in 4% PFA. All facial images are maximal intensity
projections (MIPs) that include all sections of z-stack using confocal
microscopy. Facial morphology disruptions were prevalent at both 22 and
44hpf, although the 22hpf treatment time resulted in a more severe
phenotype.
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Figure 12. Measurement outcomes after treatment with Smoothened
antagonist, Cyclopamine. Measurements of the face were performed with
control, 22 and 44hpf treatment group fish. Average measurements were
compiled with a minimum n-value of 5 and compared across control and
treatment fish. Each bar represents the average measurement value for given
treatment group and measurement category. Error bars represent the standard
deviation within the given treatment group or control. From this data it was
determined that there was a difference between 44hpf treated fish and control
fish in mouth height, width of the lower protruding mouth and width of the lower
internal mouth. While statistical difference couldn’t be determined for the 22hpf
treatment group, an obvious discrepancy exists between the upper protruding
mouth size and lower internal mouth size. Significant differences between
measurements were seen in the lower mouth external measurement (p =
0.0043) and the upper mouth internal measurement (p = 0.0476). Significance
levels were tested using a t Test comparing control and cyclopamine treated fish
face metrics.
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Figure 13. CaMK-II antibody staining. Immunolocalization using antiphosphorylated CaMK-II (anti-P-CaMK-II; phosphorylated at Thr287), and total
CaMK-II. Immunostained for P-CaMK-II in Tg(Fli1:GFP) embryos and
Immunostained for total CaMK-II in wildtype embryos. Embryos were fixed,
stained and imaged at 72hpf. P-CaMK-II can be seen around the edge of the
opening of the mouth on the image to the left and total CaMK-II can also be
seen on the boundary of the perforated fish mouth on the right.
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Figure 14. Drug treatments with KN93, a calmodulin binding site
antagonist of CaMK-II. Treatments with KN93 were at 24, 48 and 50hpf,
respectively. Once treated with KN93, the fish were incubated at 28.5°C until
72hpf when they were treated with 4% PFA and prepared for imaging. All fish
were Tg(Fli1:GFP) fish counter-stained with Rhodamine Phalloidin after being
fixed in 4% PFA. All facial images are maximal intensity projections (MIPs)
that include all sections of z-stack using confocal microscopy. Facial
morphology disruptions were seen to be primarily at 48hpf, with a boxmouthed phenotype having prevalence.
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Figure 15. Drug treatment outcomes with KN93, a calmodulin binding site
antagonist of CaMK-II. Treatments were at 24, 48, and 50hpf, respectively.
Once treated with KN93, the fish were incubated at 28.5°C until 72hpf when
they were treated with 4% PFA and prepared for imaging. Bars represent the
percentage of fish with phenotypic changes to mouth morphology, indicated as
being phenotypically normal (blue), box-shaped (orange) or cleft-like (grey).
Oddly, it was concluded that KN93 treatment caused the most significant
changes to facial development when treated at a later time point (48hpf).
Treatments at both 24 and 50hpf resulted in subtle changes to head
morphology but the most severe phenotype seen was a box-like mouth.
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Figure 16. Measurement outcomes after treatment with calmodulin
binding antagonist of CaMK-II, KN93. Measurements of the face were
performed with control, 24, 48 and 50hpf treatment group fish. Average
measurements were compiled with a minimum n-value of 5 and compared
across control and treatment fish. Each bar represents the average
measurement value for given treatment group and measurement category.
Error bars represent the standard deviation within the given treatment group or
control. From this data it was determined that there was a difference between
24hpf treated fish and control fish in mouth height (top to bottom).
Furthermore, there was a difference seen between 48hpf treated fish and
control fish in brain size and width of the mouth (both upper and lower)
internally. The most significant measurement difference (p = 0.0068) was seen
in 48hpf KN93 brain size. Significance levels were tested using a t Test
comparing control and KN93 treated fish face metrics.
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Discussion
When does the primary mouth form and what role does it have on secondary
(adult) mouth formation? For Xenopus, the Dickinson lab (VCU Biology) has established
some of the mechanisms and principals involved in the primary mouth’s formation and
eventual perforation to form the secondary mouth (reviewed in Dickinson 2016). From
their discoveries and the findings of other craniofacial researchers we were able to seek
out details of zebrafish primary mouth formation in a more informed manner. While the
mechanism for perforation of the primary mouth in zebrafish seems to be different from
that of Xenopus (Hamlett et al., 1996; Waterman and Kao, 1982), the primary mouth still
serves the essential function of connecting the foregut to the external environment. In
order to better understand this structure, we decided to investigate when the protruding
mouth is first visible in zebrafish, as this is presumably directly after perforation and
would serve as a marker for when primary mouth formation has come to pass. Initially
there were concerns that the natural body curvature of Danio would prevent proper
sectioning of the face and not allow for proper confocal imaging. Dispelling these
concerns, we were able to create a series of time point images from 36-48hpf not only
highlighting the orofacial developmental features but also validating our new imaging
technique as one that is not as limited as one may have thought. From these results we
were also able to confirm that Danio is capable of more rapid mouth formation than
other model organisms currently being studied, a significant detail to consider when
searching for novel sensitive time periods in craniofacial development. After seeing that
the imaging technique was viable in establishing when the mouth is first formed in
zebrafish, our next goal was to be able to recapitulate cleft-like phenotypes in zebrafish
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and image them in this new forward facing manner. Surprisingly, most craniofacial
research involving Danio has not been focused on the mouth, and instead is centered
on bone, cartilage, and tooth growth. We suspect that the reason for this is the ease in
which Alcian blue (cartilage stain) and Alizarin red staining (bone stain) can be used.
That being said, key developmental pathways have been implicated in proper
craniofacial / orofacial morphogenesis in zebrafish using these techniques
(Mukhopadhyay 2008; Dickinson 2016; Swartz 2011; Liu et al., 2005). The first pathway
we decided to investigate was the BMP signaling pathway. Treatment with the
antagonist DMH1 did result in orofacial clefting, which we were able to capture
qualitatively with our new imaging technique. Important to note is that our results
echoed current literature in that our earlier treatment period (24hpf) produced the most
severe orofacial defects, whereas our later treatment periods generally had no effect
(42, 48hpf). We believe the reason for this is that the earlier treatment period (before
36hpf) results in reduced bmp2b and bmp4 expression, which has been shown to be
essential in proliferation and survival of palatal precursors in zebrafish (Swartz 2011). In
order to further examine the BMP signaling pathway, we decided to see what would
happen if we had over-expression of BMP during development. Heat shocking at 18hpf
resulted in severe craniofacial defects at 72hpf, statistical analysis showed a significant
difference between mouth height and mouth width both externally and internally. We
believe the 18hpf heat shock time may have had an effect on the tail-end of neural crest
migration as neural crest cells are not fully resident to the face until 20hpf (Cusack et al.
2017). In conclusion, we were able to generate a cleft-like phenotype with both inhibition
and overexpression of BMP signaling, reinforcing our imaging method as a valuable
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way to qualitatively show the developmental role the BMP signaling pathways has. In
order to explore other signaling pathways shown to be relevant in craniofacial
development we decided to investigate the Hedgehog signaling pathway. Using the Hh
signaling smoothened antagonist cyclopamine we were able to produce cleft like
phenotypes at treatment times of both 22hpf and 44hpf. By treating at 22hpf and 44hpf
we were able to recapitulate some of the results shown in previous literature in that
treatments before 48hpf would result in clefting or at least loss of some jaw features
(Wada 2005). We hypothesize that the treatment at 22hpf had an effect on NC
migration whereas the treatment at 44hpf disrupted growth of cartilaginous features
needed for proper palatogenesis. Previously in zebrafish craniofacial research a
treatment time of 44hpf, after NC migration has occurred, would lead to solely
investigating the cartilage and bone elements of the skull developing. However, with our
imaging we were able to show that there is strength in being able to show the cleft
phenotype in relation to the other data being collected (Figure 11). Lastly we decided to
explore the role of CaMK-II in proper orofacial morphogenesis. By utilizing antibody
Immunolocalization we were able to determine that both P-CaMK-II and total CaMK-II
reside in the mouth region (Figure 13). From this we were able to determine that CaMKII must have some role in mouth regulation otherwise expression would not be seen in
the area. In order to elucidate what level of regulation CaMK-II may hold on the orofacial
region we decided to use the calmodulin binding site antagonist of CaMK-II, KN93.
Using KN93 to perturb CaMK-II signaling allowed for us to reveal whether the function
CaMK-II had in the area was significant or mundane in nature. Out of the three
treatment time points (24, 48, 50hpf) the 48hpf treatment time point had the most
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severe morphological abnormalities. This is surprising however, as an earlier treatment
time would usually result in more downstream consequences for craniofacial
development. We believe KN93 function may weaken over time, indicating that the
48hpf treatment window may have been more significant and that the role CaMK-II
plays on NC migration is not substantial (as earlier treatment times did not result in
facial abnormalities). While evaluating measurement outcomes between KN93
treatment groups we noticed that brain size was one of the most dramatically changed
values, indicating a potential role for KN93 on brain and skull formation. Establishing the
primary mouth’s formation in zebrafish, our ability to recapitulate phenotypes in a more
visually captivating manner, and the speed in which we can establish novel
mechanisms within developmental pathways shows the strength of Danio as a model
for craniofacial research. Moving forward I feel as though this imaging technique should
become standard as it is much more appealing than the current Alcian blue staining
protocol used to show loss of mandibular components. While the technique may seem
daunting initially it is not difficult to master and can be easily added to any current
zebrafish orofacial research methodology to enhance their qualitative data.
Quantitatively the potential for establishing morphometric landmarks using the forward
facing zebrafish is promising. In conclusion the zebrafish is a vastly underrated model
organism for studying mouth formation and development, something that can and
should be changed moving forward.
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